Skip to content
www.elpa.eu
MENUMENU
  • HOME
  • ABOUT US
    • Our Mission
    • ANNUAL REPORTS
    • Statutes
    • Our team
    • Internal rules
    • FINANCES
    • Governance
    • Best practice
    • Codes of conduct
    • Finance and transparency
    • SUPPORTS AND GRANTS
    • Resource library
    • European social charter
    • QUARTAL NEWS REPORT
    • ELPA supporters, collaboration and partnership
    • Statutory Audit
    • Endorsement documents
    • ISO Certificate
  • MEMBERS
    • ELPA MEMBERS
    • BECOME A MEMBER
    • BECOME A SUPPORTER
    • ELPA Working Groups
  • PROJECTS
    • Hep-CORE Study
    • ELPA UNIVERSITY
    • Hep C – From Hell to Hope
    • ELPA INTERVIEWS
    • ELPA@HOME
    • Spring European HEPATIS-HIV Testing Week
    • Spring European Testing Week
    • Time To DeLiver
  • RESEARCH
    • EIT LIVERSCREEN
    • Liverhope
    • MICROB-PREDICT
    • IP cure B
    • DECISION
    • Galaxy
    • COBALT Study
  • LIVER DISEASES
    • ELPA Working Groups
    • Hepatic encephalopathy (HE)
    • Hepatitis B (HBV)
    • Hepatitis C (HCV)
    • Hepatocellular carcinoma (HCC)
    • Nonalcoholic steatohepatitis (NASH)
    • White Paper – Liver Cancer: No patient left behind
    • Liver Cancer
      • EU Projects
    • Rare liver diseases
  • NEWS

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure

Posted on February 19, 2021 | by admin

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure
Posted in Elpa News

Post navigation

ELPA participated in Multi‐stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment
ELPA was honoured to participate in dissemination of the information and results of research project Liver Screen that was funded by EITHealth The biggest liver screening project Europe “LiverScreen: before it’s too late”

NEWS

  • 2nd A-TANGO newsletter

    2nd A-TANGO newsletter

    November 17, 2022
  • Members unanimously approved updates of ELPA Statutes, Codes of Conduct, and Internal Rules

    Members unanimously approved updates of ELPA Statutes, Codes of Conduct, and Internal Rules

    March 7, 2022
  • The first patient recruited in the IP-cure-B clinical trial

    The first patient recruited in the IP-cure-B clinical trial

    March 1, 2022
  • ELPA President Marko Korenjak-World Cancer Day

    ELPA President Marko Korenjak-World Cancer Day

    February 4, 2022
  • Merry #AlcoholFree Holidays & Happy Healthy Liver!

    Merry #AlcoholFree Holidays & Happy Healthy Liver!

    December 10, 2021

Our ultimate goal is a world without liver disease.

For any information related to our association please contact us.

© ELPA - Schuman Roundabout 2-4, Level 6,1040 Brussels, Belgium

Baybahis Hititbet 1win betmarlo betbox melbet madridbet bonus veren siteler deneme bonusu veren siteler deneme bonusu bonus veren siteler deneme bonusu deneme bonusu volvoadventure.org
© 2023 www.elpa.eu | Bootstrap WordPress Theme